Finance

Lists
PTHS:NYSEAMERICAN
Pelthos Therapeutics Inc
$7.00
-1.48%
(-0.11) 1D
Nov 19, 3:01:06 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTHS...
Open
$6.91
High
$7.81
Low
$6.76
Mkt. cap
27.50M
Avg. vol.
66.52K
Volume
61.19K
52-wk high
$31.62
52-wk low
$6.02
EPS
-$18.56
Shares outstanding
3.93M
No. of employees
92
Open
$6.91
High
$7.81
Low
$6.76
Mkt. cap
27.50M
Avg. vol.
66.52K
Volume
61.19K
52-wk high
$31.62
52-wk low
$6.02
EPS
-$18.56
Shares outstanding
3.93M
No. of employees
92
News stories
From web sources and news partners
About Pelthos Therapeutics Inc
CEO-
Employees92
Founded2002
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
9.39M
10.91M
15.60M
15.40M
Cost of goods sold
2.05M
1.86M
4.21M
4.17M
Cost of revenue
2.05M
1.86M
4.21M
4.17M
Research and development expenses
-
-
-
1.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.47M
21.10M
26.17M
18.84M
Operating expense
19.35M
22.14M
27.22M
20.92M
Total operating expenses
21.39M
23.99M
31.43M
25.09M
Operating income
-12.00M
-13.09M
-15.82M
-9.69M
Other non operating income
-14.98M
-9.63M
-3.70M
4.07M
EBT including unusual items
-28.59M
-25.07M
-23.42M
-7.90M
EBT excluding unusual items
-28.30M
-25.07M
-21.92M
-7.90M
Income tax expense
-6.92M
-
-
-
Effective tax rate
24.21%
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.66M
-25.07M
-23.42M
-7.90M
Net profit margin
-230.74%
-229.90%
-150.08%
-51.28%
Earnings per share
-2.69
-4.66
-3.79
-2.82
Interest and investment income
-
-
-
-
Interest expense
-1.31M
-2.35M
-2.39M
-2.27M
Net interest expenses
-1.31M
-2.35M
-2.39M
-2.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.79M
-11.59M
-14.50M
-8.36M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps